Trend
DailyUptrend (starting)
4 hourStrong Bearish
1 hourLeaning Bullish
15 minLeaning Bullish
5 minConsolidating
Daily trend turns down below $3.40
Key levels
Resistance$9.20
Resistance$8.40
Support$7.98
Support$7.49
Latest news & SEC filings
ProductDaxor Reports Studies Supporting Its Blood Volume Analysis in Severe Heart Failure
All DXR news →Daxor is a medical device maker whose main product is a system that gauges how much blood is circulating in a patient, paired with a disposable tracer injection and sample collection kit. Through its Scientific Medical Systems and Idant units, it also stores blood and semen for customers. The company runs a production and research site in Oak Ridge, Tennessee, and serves hospitals, imaging centers and other care providers across the United States and abroad.
Based on the company's 10-K filed Mar 28, 2012.
Nasdaq · Other
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for DXR.
Start Free Trial →Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
19
Moat Score
NONE
2/9
Piotroski Score
N/A
Altman Z-Score
Insider Signal
NEUTRAL
1 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Jefferies John | officer | Buy | 2,451 | - | Aug 28, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
-8.4%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-245.3%
FCF Growth YoY
-10.3%
Revenue Trend
UNKNOWN
SEPT Investing tracks real-time dark pool institutional trades for DXR, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:56:28 | $8.52 | 1,000 | $$9K | SELL |
| 18:29:53 | $8.40 | 1,000 | $$8K | SELL |
| 15:03:32 | $8.80 | 1,000 | $$9K | SELL |
| 18:11:44 | $8.70 | 1,152 | $$10K | SELL |
| 19:49:20 | $9.40 | 1,000 | $$9K | SELL |
5 dark pool trades shown · $$45K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for DAXOR CORP (DXR) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →DAXOR CORP (DXR) is at $8.36, down 1.88% (-$0.16) at the Nov 12, 2026 close.
Latest DXR news — Oct 14, 2026: Daxor Reports Studies Supporting Its Blood Volume Analysis in Severe Heart Failure
Analyst ratings for DXR: 2 Buy, 0 Hold, 0 Sell — consensus Buy.
DXR last reported on Aug 31, 2026: EPS -$0.66 vs -$0.06 expected — a miss of 1000.0%.
DXR does not currently pay a dividend.
Support: $7.98, $7.49, $7.10. Resistance: $8.40, $9.20, $9.61.
Insider activity: NEUTRAL, 1 buys and 0 sells in the last 90 days.
Oct 14, 2026: Daxor Reports Studies Supporting Its Blood Volume Analysis in Severe Heart Failure